Members |
targetComponentId |
T4: nyretumor med gennemvækst af fascia renalis |
American Joint Committee on Cancer cT4 (qualifier value) |
T4: testikeltumor med indvækst i scrotum med eller uden vaskulær/lymfatisk indvækst |
American Joint Committee on Cancer cT4 (qualifier value) |
T4: Thyroideatumor af uspecificeret størrelse med direkte spredning ud over thyroideakapslen |
American Joint Committee on Cancer cT4 (qualifier value) |
T4: Tumor med direkte indvækst i tilgrænsende strukturer |
American Joint Committee on Cancer cT4 (qualifier value) |
T4: Tumor med gennemvækst af cartilago cricoidea eller cartilago thyroidea og/eller med spredning til andre væv ud over larynx (trachea, bløddele i halsen, thyroidea, oesophagus) |
American Joint Committee on Cancer cT4 (qualifier value) |
T4: Tumor med indvækst gennem cartilago thyroidea og/eller med spredning til andre væv gennem larynx (trachea, bløddele i halsen, pharynx) |
American Joint Committee on Cancer cT4 (qualifier value) |
T4: Tumor med gennemvækst af cartilago thyroidea og/eller med direkte spredning til bløddele i halsen, thyroidea og/eller oesophagus |
American Joint Committee on Cancer cT4 (qualifier value) |
T4: blæretumor med indvækst i en af flg. lokalisationer: prostata, uterus, vagina, pelvisvæg, abdominalvæg |
American Joint Committee on Cancer cT4 (qualifier value) |
T4a: Blæretumor med indvækst i prostata eller uterus eller vagina |
American Joint Committee on Cancer cT4a (qualifier value) |
T4a: mammatumor med direkte spredning til thoraxvæggen |
American Joint Committee on Cancer cT4a (qualifier value) |
T4a: Tumor i colon/rectum med direkte indvækst i andre organer eller strukturer |
American Joint Committee on Cancer cT4a (qualifier value) |
T4b: Blæretumor med indvækst i pelvisvæg eller abdominalvæg |
American Joint Committee on Cancer cT4b (qualifier value) |
T4b: tumor i colon/rectum, der penetrerer viscerale peritoneum |
American Joint Committee on Cancer cT4b (qualifier value) |
T4b: Ødem (inklusive peau d'orange) eller ulceration i brysthuden eller satellitknuder i huden begrænset til samme mamma |
American Joint Committee on Cancer cT4b (qualifier value) |
T4c: mammatumor, både T4a og T4b |
American Joint Committee on Cancer cT4c (qualifier value) |
T4d: Inflammatorisk karcinom (mamma) |
American Joint Committee on Cancer cT4d (qualifier value) |
T4d: inflammatorisk karcinom i mamma med involvering af huden og thoraxvæggen ved karcinom |
American Joint Committee on Cancer cT4d (qualifier value) |
TNM tumour staging |
American Joint Committee on Cancer allowable value |
TNM tumour staging |
American Joint Committee on Cancer allowable value |
TX-stadium |
American Joint Committee on Cancer cTX (qualifier value) |
Ta: Ikke-invasivt papillært karcinom (urinveje) |
American Joint Committee on Cancer cTa (qualifier value) |
Tacaribe-virus-kompleks |
Mammarenavirus |
Tacrolimus 0.03% ointment |
Product containing precisely tacrolimus 300 microgram/1 gram conventional release cutaneous ointment (clinical drug) |
Tacrolimus 0.1% ointment |
Product containing precisely tacrolimus 1 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
Tacrolimus 1mg modified-release tablet |
Tacrolimus only product in oral dose form |
Tacrolimus 1mg prolonged-release oral tablet |
Tacrolimus only product in oral dose form |
Tacrolimus 4mg modified-release tablet |
Tacrolimus only product in oral dose form |
Tacrolimus 4mg prolonged-release oral tablet |
Tacrolimus only product in oral dose form |
Tacrolimus 5mg/1mL infusion concentrate |
Product containing precisely tacrolimus 5 milligram/1 milliliter conventional release solution for injection (clinical drug) |
tacrolimus 5 mg/ml koncentrat til infusionsvæske, ampul a 1 ml |
Product containing precisely tacrolimus 5 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Tacrolimus 5mg/mL injection |
Product containing precisely tacrolimus 5 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Tacrolimus 5mg/mL injection solution 1mL vial |
Product containing precisely tacrolimus 5 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Tacrolimus 750microgram modified-release tablet |
Tacrolimus only product in oral dose form |
Tacrolimus 750microgram prolonged-release orale tablet |
Tacrolimus only product in oral dose form |
Tacrolimus monohydrate 0.03% ointment |
Product containing precisely tacrolimus 300 microgram/1 gram conventional release cutaneous ointment (clinical drug) |
Tacrolimus monohydrate 0.1% ointment |
Product containing precisely tacrolimus 1 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
Taenia multiceps |
Taenia multiceps |
Take-down of arteriovenous shunt |
Removal of arteriovenous shunt device |
Podning for specifik organisme |
Taking swab for microbiology |
Podning fra anatomisk lokalisation |
Taking of swab |
Tamoxifen 10mg tablet |
Product containing precisely tamoxifen (as tamoxifen citrate) 10 milligram/1 each conventional release oral tablet (clinical drug) |
Tamoxifen 20mg tablet |
Product containing precisely tamoxifen (as tamoxifen citrate) 20 milligram/1 each conventional release oral tablet (clinical drug) |
Tamoxifen citrate 10mg |
Product containing precisely tamoxifen (as tamoxifen citrate) 10 milligram/1 each conventional release oral tablet (clinical drug) |
Tamoxifen citrate 10mg tablet |
Product containing precisely tamoxifen (as tamoxifen citrate) 10 milligram/1 each conventional release oral tablet (clinical drug) |
tamsulosinhydrochlorid 400 µg tablet med modificeret udløsning |
Tamsulosin only product in oral dose form |
Tamsulosin hydrochloride 400micrograms prolonged-release oral tablet |
Tamsulosin only product in oral dose form |
Tannery production worker NOS |
Tannery production worker |
Tannery production worker NOS |
Tannery production worker |
Tannin |
Tannic acid |
Tapeworm larvae |
Class Cestoda larva |
Tardive dyskinesia |
Tardive dyskinesia (disorder) |
Taxi cab driver medical examination NOS |
Taxi cab driver medical exam |
Taxi cab driver medical examination NOS |
Taxi cab driver medical exam |
lærer for mentalt handicappede |
Intellectual disability teacher |
Teacher training teacher NOS |
Teacher training teacher |
Teacher training teacher NOS |
Teacher training teacher |
Teaching principal NOS |
Teaching principal |
Teaching principal NOS |
Teaching principal |
Technetium Tc^99c^ medronate |
Technetium (99m-Tc) medronate (substance) |
technetium[99mTc]-albuminkolloid (nanostørrelse) injektionsvæske |
Product containing technetium (99m-Tc) aggregated albumin in parenteral dose form (medicinal product form) |
Technetium[99mTc] albumin colloid (nanosized) injection |
Product containing technetium (99m-Tc) aggregated albumin in parenteral dose form (medicinal product form) |
Technetium[99mTc] albumin millimicrospheres injection |
Product containing technetium (99m-Tc) aggregated albumin in parenteral dose form (medicinal product form) |
technetium[99mTc]-albumin-millimikrosfærer injektionsvæske |
Product containing technetium (99m-Tc) aggregated albumin in parenteral dose form (medicinal product form) |
Technical sales representative NOS |
Technical salesman |
Technical sales representative NOS |
Technical salesman |
Technical service advisor NOS |
Technical service adviser |
Technical service advisor NOS |
Technical service adviser |
Technologist NOS |
Technologist |
Technologist NOS |
Technologist |
Tænder dækket med plak |
Dental plaque on teeth |
Teichococcus ludipueritiae |
Roseomonas ludipueritiae (organism) |
Telephone/mail supervisor NOS |
Telephone/radio/mail supervisor |
Telephone/mail supervisor NOS |
Telephone/radio/mail supervisor |
telefonrapport |
Telephoned report (record artifact) |
Telephonist NOS |
Telephone switchboard operator |
Telephonist NOS |
Telephone switchboard operator |
Teleradiotherapy of unlisted particulate radiation |
External beam radiation therapy procedure |
ekstern strålebehandling med radiumkrave |
Radium therapy |
Temperature of blood |
Core body temperature measured in blood (observable entity) |
Temporary code for ultrastructural feature |
Subcellular structure |
Temporary urinary catheter |
Urinary catheter |
temporomandibulær artroplastik, ikke nærmere specificeret |
Repair of temporomandibular joint (procedure) |
Temporomandibular arthroplasty NOS |
Repair of temporomandibular joint (procedure) |
Temporomandibular joint X-ray |
Plain X-ray of temporomandibular joint (procedure) |
temsirolimus 25 mg/ml injektionsvæske, opløsning, hætteglas + diluent |
Temsirolimus only product |
Temsirolimus 25mg/mL powder for conventional release solution for injection vial |
Temsirolimus only product |
abort nr. 10 |
Past pregnancy history of multiple induced termination of pregnancy |
Seneforlængende indgreb |
Surgical lengthening - action |
ruptur af sene, ikke nærmere specificeret |
Traumatic rupture of tendon (disorder) |
Tendon rupture NOS |
Traumatic rupture of tendon (disorder) |
senetranspositionsindgreb |
Surgical transfer - action (qualifier value) |
Tendoperiostitis |
Tenoperiostitis (disorder) |
tenecteplase 8.000 IE (40 mg) pulver og solvens til injektionsvæske, opløsning, hætteglas |
Product containing only tenecteplase (medicinal product) |
Tenecteplase 8000iu(40mg) powder for conventional release solution for injection vial |
Product containing only tenecteplase (medicinal product) |
Tenesmi, ikke nærmere specificeret |
Tenesmus of anus and/or rectum (finding) |
Tenesmus NOS |
Tenesmus of anus and/or rectum (finding) |
Teniposide 10mg/mL injection solution 5mL vial |
Product containing precisely teniposide 10 milligram/1 milliliter conventional release solution for injection (clinical drug) |
teniposid 50 mg injektionsvæske, opløsning, ampul |
Product containing precisely teniposide 10 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Tenosynovitis of foot and ankle, NEC |
Tenosynovitis |
Tenosynovitis of hand and wrist, NEC |
Tenosynovitis |
Tenure - Dentine bonding agent |
Dentine bonding agent |